Progress in the field of pancreatic endocrine tumors in Japan.
Since the first report of pancreatic endocrine tumors by Wilder et al. in 1927 and the development of radioimmunoassay of gut hormone by Berson and Yallow in 1961, Japanese clinicians and scientists have contributed significantly in the reporting, investigation, and management of patients with pancreatic endocrine tumors and other multiple endocrine neoplasia. This article summarizes our contribution in this field and contrasts our experiences with those reported in the English literature.